Page last updated: 2024-10-24

water transmembrane transporter activity

Definition

Target type: molecularfunction

Enables the transfer of water (H2O) from one side of a membrane to the other. [GOC:ai]

Water transmembrane transporter activity refers to the movement of water molecules across biological membranes. This crucial process is facilitated by specialized proteins known as aquaporins. Aquaporins are integral membrane proteins that form channels through which water can pass rapidly and selectively. The molecular mechanism underlying water transport by aquaporins involves a series of intricate interactions between water molecules and the protein's amino acid residues. The aquaporin channel is typically lined by hydrophilic residues, which attract water molecules and allow them to move through the channel. However, the channel also contains a narrow constriction point, known as the "selectivity filter," which prevents the passage of larger molecules such as ions and solutes. This selectivity filter ensures that only water molecules can traverse the channel, maintaining the integrity of cellular and organellar compartments. The movement of water through aquaporins is driven by the osmotic gradient across the membrane. This gradient arises from differences in the concentration of solutes between the two compartments. Water molecules flow from areas of high water concentration (low solute concentration) to areas of low water concentration (high solute concentration), driven by the tendency to equalize the solute concentration. This process is essential for numerous physiological functions, including maintaining cell volume, regulating blood pressure, and facilitating nutrient transport. Aquaporin-mediated water transport is highly regulated and influenced by factors such as pH, temperature, and the presence of specific ligands. The dysregulation of aquaporin activity has been implicated in various diseases, including diabetes, kidney disease, and neurological disorders.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Aquaporin-1An aquaporin-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P29972]Homo sapiens (human)
Sodium/glucose cotransporter 1A sodium/glucose cotransporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P13866]Homo sapiens (human)

Compounds (16)

CompoundDefinitionClassesRoles
phloretindihydrochalconesantineoplastic agent;
plant metabolite
phlorhizinaryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative
antioxidant;
plant metabolite
vexibinolsophoraflavanone G : A tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2' as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8'.

vexibinol: flavanol from Sophora; structure in first source; RN given refers to (S-(R*,S*))-isomer
(2S)-flavan-4-one;
4'-hydroxyflavanones;
tetrahydroxyflavanone
antimalarial;
antimicrobial agent;
antioxidant;
plant metabolite
2',4',6'-Trihydroxydihydrochalconechalcones
cgp 71683 anaphthalenes;
sulfonic acid derivative
2',4',6'-trihydroxychalconepinocembrin chalcone : A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2', 4' and 6' respectively.

pinocembrin chalcone: isolated from Helichrysum trilineatum; structure in first source
chalconesantifungal agent;
plant metabolite
sergliflozin etabonatesergliflozin: a hypoglycemic agent that inhibits SGLT2 sodium-glucose transporter; structure in first sourceglycoside
remogliflozin etabonateremogliflozin etabonate: orally administered hypoglycemic agent; structure in first sourceglycoside
dapagliflozinaromatic ether;
C-glycosyl compound;
monochlorobenzenes
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
ipragliflozinglycoside
empagliflozinaromatic ether;
C-glycosyl compound;
monochlorobenzenes;
tetrahydrofuryl ether
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitoldiarylmethane
nothofaginnothofagin: a dihydrochalcone
canagliflozincanagliflozin hydrate : A hydrate that is the hemihydrate form of canagliflozin. Used for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2.C-glycosyl compound;
organofluorine compound;
thiophenes
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
pf 04971729ertugliflozin: structure in first sourcediarylmethane
deberza2-benzofurans